GlassScriptPhysician profile
Yechiel Zagelbaum
NPI 1558452730
$650.92
in general payments reported to CMS, 2019-2025
10 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.73 · 2020: $43.46 · 2021: $80.38 · 2022: $94.14 · 2023: $154 · 2024: $149 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $305.10 | 2022-2025 | Vpriv |
| Glaxosmithkline, LLC. | $147.27 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Sanofi Pasteur INC. | $46.10 | 2021-2024 | |
| Pfizer INC. | $45.86 | 2021-2025 | |
| Seqirus USA INC | $30.97 | 2025 | Flucelvax |
| Lnhc, INC | $19.76 | 2025 | Zelsuvmi |
| Strongbridge US INC. | $18.05 | 2020 | |
| Verrica Pharmaceuticals INC. | $13.64 | 2024 | Ycanth |
| Genzyme Corporation | $13.29 | 2021 | |
| Organon LLC | $10.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yechiel Zagelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.